Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.

OBJECTIVERecent efforts to improve visualization of 5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PPIX) fluorescence resulted in a dual-labeling technique, combining it with fluorescein sodium in a prototype setup. Fluorescein identifies regions with blood-brain barrier breakdown in gliomas. However, normally perfused and edematous brain fluoresces unselectively, with strong background enhancement. The aim of this study was to test the feasibility of a novel, integrated filter combination using porphyrins for selective tumor identification and fluorescein for background enhancement.METHODSA microscope with a novel built-in filter system (YB 475) for visualizing both fluorescein and 5-ALA-induced porphyrins was used. Resection limits were identified with the conventional BLUE 400 filter system. Six patients harboring contrast ring-enhancing lesions were analyzed.RESULTSThe complete surgical field could now be illuminated. Fluorescein was helpful for improving background visualization, and enhancing dura, edematous tissue, and cortex. Overlapping regions with both fluorophores harbored merged orange fluorescence. PPIX fluorescence was better visualized, even in areas beyond a normal working distance of approximately 25 cm, where the BLUE 400 filters recognized no or weak fluorescence.CONCLUSIONSThe novel filter system improved general tissue brightness and background visualization, enhancing fluorescence-guided tumor resection. Furthermore, it appears promising from a scientific perspective, enabling the simultaneous and direct observation of areas with blood-brain barrier breakdown and PPIX fluorescence.

[1]  David W Roberts,et al.  Fluorescein Guidance in Glioblastoma Resection. , 2017, The New England journal of medicine.

[2]  Kathleen Seidel,et al.  Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. , 2012, Neurosurgery.

[3]  Brian W Pogue,et al.  Review of Neurosurgical Fluorescence Imaging Methodologies , 2010, IEEE Journal of Selected Topics in Quantum Electronics.

[4]  W. Stummer,et al.  Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients. , 2018, Journal of neurosurgery.

[5]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[6]  Xian-Fu Zhang,et al.  Fluorescence Properties of Twenty Fluorescein Derivatives: Lifetime, Quantum Yield, Absorption and Emission Spectra , 2014, Journal of Fluorescence.

[7]  W. Stummer,et al.  Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery—review of the literature , 2017, Neurosurgical Review.

[8]  Walter Stummer,et al.  Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery , 2012, Journal of Neuro-Oncology.

[9]  W. Stummer,et al.  Fluorescence Imaging/Agents in Tumor Resection. , 2017, Neurosurgery clinics of North America.

[10]  C. Wirtz,et al.  Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival , 2015, PloS one.

[11]  Alexander Brawanski,et al.  Sodium fluorescein–guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery—a feasibility study , 2013, Acta Neurochirurgica.

[12]  S. Eljamel 5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature , 2015, International journal of molecular sciences.

[13]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[14]  Francesco Acerbi,et al.  Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases , 2013, Acta Neurochirurgica.

[15]  M. Kubista,et al.  Absorption and fluorescence properties of fluorescein , 1995 .

[16]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.

[17]  M. Berger,et al.  Extent of resection influences outcomes for patients with gliomas. , 2011, Revue neurologique.

[18]  Oren Sagher,et al.  Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. , 2012, Journal of neurosurgery.

[19]  W. Stummer,et al.  Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.

[20]  W. Stummer Poor man’s fluorescence? , 2015, Acta Neurochirurgica.

[21]  H. Reulen,et al.  Formation and resolution of human peritumoral brain edema. , 1994, Acta neurochirurgica. Supplementum.

[22]  Walter Stummer,et al.  Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery , 2015, Acta Neurochirurgica.

[23]  J. Rutka,et al.  Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance. , 2015, Journal of neurosurgery.

[24]  K Sartor,et al.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1994, Neurosurgery.

[25]  Francesco Acerbi,et al.  Is fluorescein-guided technique able to help in resection of high-grade gliomas? , 2014, Neurosurgical focus.

[26]  W. Stummer,et al.  Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas , 2017, Neurosurgery.

[27]  J. Griffiths,et al.  Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin , 2012, British Journal of Cancer.

[28]  W. Stummer Factors confounding fluorescein-guided malignant glioma resections: edema bulk flow, dose, timing, and now: imaging hardware? , 2015, Acta Neurochirurgica.

[29]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[30]  W. Stummer,et al.  Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note. , 2017, Journal of neurosurgery.

[31]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[32]  Laurent Mahieu-Williame,et al.  Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas , 2013, Biomedical optics express.

[33]  G. Reifenberger,et al.  Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  F. Floeth,et al.  The value of metabolic imaging in diagnosis and resection of cerebral gliomas , 2005, Nature Clinical Practice Neurology.

[35]  J. Uhm,et al.  Overall survival in patients with glioblastoma before and after bevacizumab approval , 2018, Current Medical Research and Opinion.

[36]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[37]  Walter Stummer,et al.  Where and When to Cut? Fluorescein Guidance for Brain Stem and Spinal Cord Tumor Surgery—Technical Note , 2017, Operative neurosurgery.

[38]  P. Ferroli,et al.  What is the best timing for fluorescein injection during surgical removal of high-grade gliomas? , 2015, Acta Neurochirurgica.

[39]  Binsheng Zhao,et al.  Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. , 2017, Journal of neurosurgery.

[40]  Herbert Stepp,et al.  5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging , 2013, Neurosurgery.

[41]  Answer to: “Sodium fluorescein-guided resection under the YELLOW 560-nm surgical microscope filter in malignant brain tumor surgery—a feasibility study” (April 2013, Volume 155, Issue 4, pp 693–69) , 2013, Acta Neurochirurgica.

[42]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.